Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures
Source abstract
Abstract
Cancer stem cells (CSCs) are responsible for drug resistance, tumor recurrence, and metastasis in several cancer types, making their eradication a primary objective in cancer therapy. Glioblastoma Multiforme (GBM) tumors are usually composed of a highly infiltrating CSC subpopulation, which has Nestin as a putative marker. Since the majority of these infiltrating cells are able to elude conventional therapies, we have developed gold nanorods (AuNRs) functionalized with an engineered peptide capable of specific recognition and selective eradication of Nestin positive infiltrating GBM-CSCs. These AuNRs generate heat when irradiated by a near-infrared laser, and cause localized cell damage. Nanoparticle internalization assays performed with GBM-CSCs or Nestin negative cells cultured as two-dimensional (2D) monolayers or embedded in three-dimensional (3D) biodegradable-hydrogels of tunable mechanical properties, revealed that the AuNRs were mainly internalized by GBM-CSCs, and not by Nestin negative cells. The AuNRs were taken up via energy-dependent and caveolae-mediated endocytic mechanisms, and were localized inside endosomes. Photothermal treatments resulted in the selective elimination of GBM-CSCs through cell apoptosis, while Nestin negative cells remained viable. Results also indicated that GBM-CSCs embedded in hydrogels were more resistant to AuNR photothermal treatments than when cultured as 2D monolayers. In summary, the combination of our engineered AuNRs with our tunable hydrogel system has shown the potential to provide an in vitro platform for the evaluation and screening of AuNR-based cancer therapeutics, leading to a substantial advancement in the application of AuNRs for targeted GBM-CSC therapy. Statement of significance There is an urgent need for reliable and efficient therapies for the treatment of Glioblastoma Multiforme (GBM), which is currently an untreatable brain tumor form with a very poor patient survival rate. GBM tumors are mostly comprised of cancer stem cells (CSCs), which are responsible for tumor reoccurrence and therapy resistance. We have developed gold nanorods functionalized with an engineered peptide capable of selective recognition and eradication of GBM-CSCs via heat generation by nanorods upon NIR irradiation. An in vitro evaluation of nanorod therapeutic activities was performed in 3D synthetic-biodegradable hydrogel models with distinct biomechanical cues, and compared to 2D cultures. Results indicated that cells cultured in 3D were more resistant to photothermolysis than in 2D systems.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer Cells and Metastasis · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (67)
Show source-provided references
1. Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies10.1007/s00005-012-0203-0 ↗
2. The WHO classification of tumours of the central nervous system10.1007/s00401-007-0243-4 ↗
3. Glioblastoma and stem cells
4. Identification of a cancer stem cell in human brain tumors
5. Identification of human brain tumour initiating cells10.1038/nature03128 ↗
6. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma10.1158/0008-5472.CAN-04-1364 ↗
7. Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells
8. Expression of the class VI intermediate filament Nestin in human central nervous system tumors
9. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients10.1186/1756-9966-27-85 ↗
10. Identification of a peptide that interacts with Nestin protein expressed in brain cancer stem cells10.1016/j.biomaterials.2011.07.048 ↗
11. Cell surface Nestin is a biomarker for glioma stem cells10.1016/j.bbrc.2013.03.021 ↗
12. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI10.1016/j.biomaterials.2011.10.071 ↗
13. Targeted delivery of tumor suppressor microRNA-1 by transferrin- conjugated Lipopolyplex Nanoparticles to patient-derived glioblastoma stem cells10.2174/1389201015666141031105234 ↗
14. Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody, Nanomedicine Nanotechnology
15. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma10.1158/0008-5472.CAN-10-1022 ↗
16. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors10.4161/cbt.11.5.14410 ↗
17. Au nanoparticles target cancer10.1016/S1748-0132(07)70016-6 ↗
18. Optical studies of dynamics in noble metal nanostructures10.1021/cr1002547 ↗
19. Medical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anticancer nanodrugs10.1166/jbn.2011.1324 ↗
20. Size matters: gold nanoparticles in targeted cancer drug delivery10.4155/tde.12.21 ↗
21. Tunable nanostructures as photothermal theranostic agents10.1007/s10439-011-0472-5 ↗
22. Synthesis, physico-chemical properties, and biomedical applications of gold nanorods—a review10.1166/jbn.2016.2218 ↗
23. The optical properties of metal nanoparticles: the influence of size, shape, and dielectric environment10.1021/jp026731y ↗
24. Anisotropic metal nanoparticles: synthesis, assembly, and optical applications10.1021/jp0516846 ↗
25. Taking cell-matrix adhesions to the third dimension10.1126/science.1064829 ↗
26. The multicellular tumor spheroid model for high-throughput cancer drug discovery10.1517/17460441.2012.708334 ↗
27. Multi-parametric hydrogels support 3D invitro bioengineered microenvironment models of tumour angiogenesis10.1016/j.biomaterials.2015.02.124 ↗
28. Engineering tumors with 3D scaffolds10.1038/nmeth1085 ↗
29. Biomaterials and emerging anticancer therapeutics: engineering the microenvironment10.1038/nrc.2015.3 ↗
30. Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells10.1016/j.biomaterials.2009.07.054 ↗
31. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation10.1186/1741-7007-10-29 ↗
32. Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche10.1158/0008-5472.CAN-13-1355 ↗
33. Bioengineered scaffolds for 3D analysis of glioblastoma proliferation and invasion10.1007/s10439-014-1223-1 ↗
34. Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform10.1016/j.biomaterials.2011.07.005 ↗
35. Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM10.1016/j.biomaterials.2013.09.034 ↗
36. Ex vivo cultures of glioblastoma in three-dimensional hydrogel maintain the original tumor growth behavior and are suitable for preclinical drug and radiation sensitivity screening10.1016/j.yexcr.2013.12.010 ↗
37. Regulation of glioma cell phenotype in 3D matrices by hyaluronic acid10.1016/j.biomaterials.2013.06.024 ↗
38. Glioblastoma behaviors in three-dimensional collagen-hyaluronan composite hydrogels10.1021/am402097j ↗
39. Defined polymer-peptide conjugates to form cell-instructive starPEG-heparin matrices in situ10.1002/adma.201300691 ↗
40. Quantitative replacement of cetyl trimethylammonium bromide by cationic thiol ligands on the surface of gold nanorods and their extremely large uptake by cancer cells10.1002/ange.201107304 ↗
41. BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis10.1073/pnas.101109698 ↗
42. A simplified lead citrate stain for use in electron microscopy10.1083/jcb.25.2.407 ↗
43. Proline: the distribution, frequency, positioning, and common functional roles of proline and polyproline sequences in the human proteome10.1371/journal.pone.0053785 ↗
44. Sequence, structure, and function of peptide self-assembled monolayers10.1021/ja3006868 ↗
45. Development of nonfouling polypeptides with uniform alternating charges by polycondensation of the covalently bonded dimer of glutamic acid and lysine10.1039/C3TB21333A ↗
46. Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects10.1002/smll.200801546 ↗
47. Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells10.1002/smll.200700217 ↗
48. Surface chemistry, charge and ligand type impact the toxicity of gold nanoparticles to Daphnia magna10.1039/C4EN00006D ↗
49. Surface chemistry of gold nanorods: origin of cell membrane damage and cytotoxicity10.1039/c3nr01626a ↗
50. Enhanced percolation and gene expression in tumor hypoxia by PEGylated polyplex micelles10.1038/mt.2009.119 ↗
51. Colloidally stable and surfactant-free protein-coated gold nanorods in biological media10.1021/acsami.5b00335 ↗
52. The most effective gold nanorod size for plasmonic photothermal therapy: theory and in vitro experiments10.1021/jp409298f ↗
53. Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells10.1074/jbc.M704205200 ↗
54. Hes3 regulates cell number in cultures from glioblastoma multiforme with stem cell characteristics10.1038/srep01095 ↗
55. Heparin desulfation modulates VEGF release and angiogenesis in diabetic wounds10.1016/j.jconrel.2015.10.028 ↗
56. Mechanical characterization of human brain tissue10.1016/j.actbio.2016.10.036 ↗
57. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses10.1371/journal.pone.0010431 ↗
58. Fibronectin expression in glioblastomas promotes cell cohesion, collective invasion of basement membrane in vitro and orthotopic tumor growth in mice10.1038/onc.2013.305 ↗
59. Glycosaminoglycan-based hydrogels to modulate heterocellular communication in in vitro angiogenesis models10.1038/srep04414 ↗
60. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells10.1021/nl052396o ↗
61. Controlling the cellular uptake of gold nanorods10.1021/la062642r ↗
62. Gold hybrid nanoparticles for targeted phototherapy and cancer imaging10.1088/0957-4484/21/10/105105 ↗
63. Porous silicon nanoparticles for cancer photothermotherapy10.1186/1556-276X-6-321 ↗
64. Chemosensitivity of glioma cells in vitro: a meta analysis10.1007/s004320050305 ↗
65. The ABCG2 resistance network of glioblastoma10.4161/cc.8.18.9504 ↗
66. Chemotherapy resistance of glioblastoma stem cells10.1038/sj.cdd.4401872 ↗
67. Size-Dependent Localization and Penetration of Ultrasmall Gold Nanoparticles in Cancer Cells, Multicellular Spheroids, and Tumors in Vivo10.1021/nn301282m ↗